slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30,05 CNY | +1,90% | +1,11% | -27,52% |
03:05 | Huadong Medicine's winst in 2023 springt 14% omhoog | MT |
17/04 | Huadong Medicine Co., Ltd rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 14 061
Verkoop per activiteit
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Business
67,9
%
| 24 112 | 69,8 % | 25 601 | 67,9 % | +6,18% |
Manufacturing
30,1
%
| 10 456 | 30,3 % | 11 347 | 30,1 % | +8,52% |
International Medical Beauty
4,4
%
| 812 | 2,3 % | 1 664 | 4,4 % | +104,97% |
Inter-segment Elimination
-3,0
%
| -962 | -2,8 % | -1 124 | -3,0 % | +16,79% |
Other Business
0,6
%
| 146 | 0,4 % | 226 | 0,6 % | +55,26% |
Verkoop per regio
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
96,9
%
| 33 883 | 98,0 % | 36 549 | 96,9 % | +7,87% |
International
3,1
%
| 680 | 2,0 % | 1 165 | 3,1 % | +71,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hong Lan Ma
DFI | Director of Finance/CFO | 53 | - |
Bang Liang Li
CHM | Chairman | 78 | 01-01-72 |
Dong Zhou Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Li Hong Xie
IRC | Investor Relations Contact | - | - |
Bo Chen
SEC | Corporate Secretary | 52 | 12-07-10 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bang Liang Li
CHM | Chairman | 78 | 01-01-72 |
Wei Kang
BRD | Director/Board Member | 56 | - |
Liang Lü
CEO | Chief Executive Officer | 50 | 01-04-10 |
Hang Fu
BRD | Director/Board Member | 60 | - |
Yun Qin
BRD | Director/Board Member | 54 | 01-01-06 |
Ling Min Shao
BRD | Director/Board Member | 62 | 01-01-81 |
Lan Yang
BRD | Director/Board Member | 55 | - |
Xiao Ming Zhong
BRD | Director/Board Member | 62 | - |
Liang Zhu
BRD | Director/Board Member | 47 | - |
Yi Mei Wu
BRD | Director/Board Member | 60 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 758 943 348 | 734 399 391 ( 41,75 %) | 4 615 800 ( 0,2624 %) | 41,75 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
HEIDELBERG PHARMA AG 34.99% | 16 304 560 | 34.99% | 54 939 845 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,52% | 7,27 mld. | |
+12,45% | 69,11 mld. | |
+5,64% | 25,91 mld. | |
+5,02% | 8,01 mld. | |
-3,28% | 7,91 mld. | |
-0,67% | 4,51 mld. | |
+21,54% | 4,48 mld. | |
-2,45% | 3,95 mld. | |
-3,99% | 3,79 mld. | |
+23,90% | 3,7 mld. |
- Beurs
- Aandelen
- Koers 000963
- Onderneming Huadong Medicine Co., Ltd